Review Note

Last Update: 12/31/2023 10:08 PM

Current Deck: Everything::Internal Medicine (I.M. Anki)::Infectious Diseases (AnkID)

Published

The 3 FDA approved regimens for PrEP are {{c1::TDF-emtricitabine}}, {{c1::TAF-emtricitabine}}, and {{c3::cabotegravir::long-acting injectable}}

Note 1: TDF-emtricitabine (Truvada); TAF-emtricitabine (Discovy)
Note 2: Confirmed CAB is FDA approved, not cabenuva but we often give cabenuva

ID::Virus::RNA::Single_stranded::Positive_stranded::Enveloped::Retroviridae::HIV Pharm::Antivirals::ART Pharm::PrEP

No pending suggestions for this note.